Unipolare Depression Langfassung - Versorgungsleitlinien.de
Unipolare Depression Langfassung - Versorgungsleitlinien.de
Unipolare Depression Langfassung - Versorgungsleitlinien.de
Sie wollen auch ein ePaper? Erhöhen Sie die Reichweite Ihrer Titel.
YUMPU macht aus Druck-PDFs automatisch weboptimierte ePaper, die Google liebt.
607. Roose SP. <strong>Depression</strong>, anxiety, and the cardiovascular system: the psychiatrist's perspective.<br />
J Clin Psychiatry 2001;62 Suppl 8:19-22.<br />
608. Knegtering H, Eijck M, Huijsman A. Effects of anti<strong>de</strong>pressants on cognitive functioning of<br />
el<strong>de</strong>rly patients. A review. Drugs Aging 1994;5(3):192-9.<br />
609. Pollock BG, Mulsant BH, Nebes R, Kirshner MA, Begley AE, Mazumdar S, Reynolds CF, III.<br />
Serum anticholinergicity in el<strong>de</strong>rly <strong>de</strong>pressed patients treated with paroxetine or nortriptyline.<br />
Am J Psychiatry 1998;155(8):1110-2.<br />
610. Mavrogiorgou P, Hegerl U. Neurologische, neuromuskuläre und neurotoxische Effekte <strong>de</strong>r<br />
Lithiumbehandlung. In: Müller-Oerlinghausen B, Greil W, Berghöfer A, editors. Die<br />
Lithiumbehandlung. Berlin: Springer; 1997. p. 329-41<br />
611. Böker H, Bran<strong>de</strong>nberger M, Schopper C. Neurotoxische Enzephalopathie unter<br />
Kombinationsbehandlung mit Lithium und Risperidon bei einer Patientin mit schizoaffektiver<br />
Störung. Psychiatr Prax 2007;34(1):38-41.<br />
612. Sproule BA, Hardy BG, Shulman KI. Differential pharmacokinetics of lithium in el<strong>de</strong>rly patients.<br />
Drugs Aging 2000;16(3):165-77.<br />
613. Lord SR, Anstey KJ, Williams P, Ward JA. Psychoactive medication use, sensori-motor<br />
function and falls in ol<strong>de</strong>r women. Br J Clin Pharmacol 1995;39(3):227-34.<br />
614. Ray WA, Griffin MR, Schaffner W, Baugh DK, Melton LJ, III. Psychotropic drug use and the<br />
risk of hip fracture. N Engl J Med 1987;316(7):363-9.<br />
615. Ray WA, Griffin MR, Malcolm E. Cyclic anti<strong>de</strong>pressants and the risk of hip fracture. Arch<br />
Intern Med 1991;151(4):754-6.<br />
616. Ruthazer R, Lipsitz LA. Anti<strong>de</strong>pressants and falls among el<strong>de</strong>rly people in long-term care. Am<br />
J Public Health 1993;83(5):746-9.<br />
617. Thapa PB, Gi<strong>de</strong>on P, Cost TW, Milam AB, Ray WA. Anti<strong>de</strong>pressants and the risk of falls<br />
among nursing home resi<strong>de</strong>nts. N Engl J Med 1998;339(13):875-82.<br />
618. Liu B, An<strong>de</strong>rson G, Mittmann N, To T, Axcell T, Shear N. Use of selective serotonin-reuptake<br />
inhibitors of tricyclic anti<strong>de</strong>pressants and risk of hip fractures in el<strong>de</strong>rly people. Lancet<br />
1998;351(9112):1303-7.<br />
619. Gill D, Hatcher S. Anti<strong>de</strong>pressants for <strong>de</strong>pression in people with physical illness. Cochrane<br />
Database Syst Rev 2000;(2):CD001312.<br />
620. Reynolds CF, III, Dew MA, Pollock BG, Mulsant BH, Frank E, Miller MD, Houck PR,<br />
Mazumdar S, Butters MA, Stack JA, Schlernitzauer MA, Whyte EM, Gil<strong>de</strong>ngers A, Karp J,<br />
Lenze E, Szanto K, Bensasi S, Kupfer DJ. Maintenance treatment of major <strong>de</strong>pression in old<br />
age. N Engl J Med 2006;354(11):1130-8.<br />
621. Bains J, Birks JS, Dening TR. The efficacy of anti<strong>de</strong>pressants in the treatment of <strong>de</strong>pression<br />
in <strong>de</strong>mentia. Cochrane Database Syst Rev 2002;(4):CD003944.<br />
622. Petrovic M, <strong>de</strong> Paepe P, van Bortel L. Pharmacotherapy of <strong>de</strong>pression in old age. Acta Clin<br />
Belg 2005;60(3):150-6.<br />
623. Viguera AC, Cohen LS, Bal<strong>de</strong>ssarini RJ, Nonacs R. Managing bipolar disor<strong>de</strong>r during<br />
pregnancy: weighing the risks and benefits. Can J Psychiatry 2002;47(5):426-36.<br />
624. Williams G, King J, Cunningham M, Stephan M, Kerr B, Hersh JH. Fetal valproate syndrome<br />
and autism: additional evi<strong>de</strong>nce of an association. Dev Med Child Neurol 2001;43(3):202-6.<br />
625. Matalon S, Schechtman S, Goldzweig G, Ornoy A. The teratogenic effect of carbamazepine: a<br />
meta-analysis of 1255 exposures. Reprod Toxicol 2002;16(1):9-17.<br />
626. Haddad PM, An<strong>de</strong>rson IM. Recognising and managing anti<strong>de</strong>pressant discontinuation<br />
symptoms. Adv Psychiatr Treat 2007;13:447-57.<br />
627. Simon GE, Cunningham ML, Davis RL. Outcomes of prenatal anti<strong>de</strong>pressant exposure. Am J<br />
Psychiatry 2002;159(12):2055-61.<br />
628. Alwan S, Reefhuis J, Rasmussen SA, Olney RS, Friedman JM. Use of selective serotoninreuptake<br />
inhibitors in pregnancy and the risk of birth <strong>de</strong>fects. N Engl J Med<br />
2007;356(26):2684-92.<br />
© 2009 232